Post #43 My Father the Pediatrician

I recently wrote a new book geared to help parents have more meaningful conversations with their pediatrician and which will hopefully save them a copay or two as well!  As I reflect back on the five year journey in writing this book, I wanted to highlight the contributions of my biggest influence – my dad.In the summer of 1973, my father, thirty years at the time, boarded a plane with his best friend to fly overseas for the very first time in his life.  Having recently finished medical school and his mandatory army training in South Korea, he was headed to the United States to begin his residency in Passaic, New Jersey.  He would leave his recently betrothed and pregnant wife behind to pave the way for a better life in the land of opportunity.On a layover in Tokyo, a fancy new camera caught my dad’s eye.  Japan at the time was light years ahead of Korea in terms of technology and my father reckoned that electronics were cheaper in Tokyo than they would be in New Jersey.  He and his friend saw an easy opportunity to arbitrage a quick profit and spent what little money they had in hopes of selling the camera as soon as they immigrated into the States.  As fate would have it, the camera was cheaper in America – is a good deal ever to be found at the airport other than possibly duty-free goods?With even less money now but a fancy state-of-the-art camera to chronicle his adventures, my father began working long hours and prepar...
Source: A Pediatrician's Blog - Category: Pediatrics Source Type: blogs

Related Links:

Jewel Pfaffroth could barely move while she pumped. She had struggled since her son was born in April to produce breast milk—he was underweight at his first doctor’s appointment, and she immediately had to supplement with formula. Her doctor had recommended she sit at specific angles while she pumped—“to let gravity do its thing”—but those positions caused her such intense backaches that she couldn’t do basic things like carrying her baby. Yet despite the debilitating pain, she was pumping twice a day to create less than one-tenth of what her son ate. It was crucial to her that he ...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 nationpod Source Type: news
(Natural News) Back in June, the New England Journal of Medicine (NEJM) published a bogus study claiming that Wuhan coronavirus (Covid-19) “vaccines” are perfectly “safe and effective” for pregnant women to take. A few months later, the NEJM was forced to issue a correction. Entitled, “mRNA Covid-19 Vaccines in Pregnant Women,” the original study by...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
This study aims to systematically review and synthesize the evidence on the safety data from the published COVID-19 vaccine trials. This study followed PRISMA guidelines. We searched three major electronic databases (PubMed, Embase, and Google Scholar) for published studies between Dec 2019 and 2020. Eligible study designs were randomized trials and pre-and post-intervention evaluations. Descriptive findings of included studies were reported stratified by target population, setting, outcomes, and overall results. From PubMed, Embase, WHO database, and Google Scholar screened titles and abstracts, 11 studies were identified...
Source: Indian Journal of Clinical Biochemistry - Category: Biochemistry Source Type: research
In this retrospective cohort study, the response to routinely administered Haemophilus influenzae type B vaccine, pneumococcal and pertussis vaccinations in 27 children exposed to antitumor necrosis factor alpha (anti-TNFα) during pregnancy was measured. The overall vaccination response seems comparable for children exposed to anti-TNFα and healthy infants. After primary vaccination series, inadequate response was present in some patients and might be related to exposure to anti-TNFα.
Source: The Pediatric Infectious Disease Journal - Category: Infectious Diseases Tags: Immunology and Host Response Source Type: research
This study compared approximately 390,000 people who received the Company’s single-shot COVID-19 vaccine versus approximately 1.52 million unvaccinated people matched on age, sex, time, three-digit zip code, and comorbidities and predictors for COVID-19 infection severity.This study is a longitudinal cohort design, using robust propensity matching methods to create a comparator cohort to assess real-world VE. All analyses were performed using the Aetion Evidence Platform, which is a scientifically validated software that is also used by regulators, payers, and health technology assessment bodies to assess the safety,...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
Singapore Med J. 2021 Sep 21. doi: 10.11622/smedj.2021097. Online ahead of print.NO ABSTRACTPMID:34544209 | DOI:10.11622/smedj.2021097
Source: Singapore Medical Journal - Category: General Medicine Authors: Source Type: research
September 19, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson &Johnson today announced preliminary results from the Phase 1b CHRYSALIS-2 (NCT04077463) study evaluating RYBREVANT® (amivantamab-vmjw) in combination with lazertinib in the treatment of patients with non-small cell lung cancer (NSCLC) characterized by epidermal growth factor receptor (EGFR) exon 19 deletion or L858R mutations whose disease had progressed after treatment with osimertinib and platinum chemotherapy.[i] While previously reported results have demonstrated durable responses with RYBREVANT® in combination with ...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
September 19, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson &Johnson today announced a new analysis from the CHRYSALIS (NCT02609776) study evaluating RYBREVANT® (amivantamab-vmjw) monotherapy and a combination regimen with lazertinib in advanced non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations who progressed after osimertinib.[1] The analysis showed higher activity and longer duration of response (DOR) in patients treated with the combination therapy, demonstrating the potential benefit of targeting the extracellular (outer) and cataly...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
In conclusion an individualized approach should be provided by a multidisciplinary team for the management of pregnant women with COVID-19 to achieve favorable outcomes.PMID:34536988 | DOI:10.3906/sag-2106-134
Source: Turkish Journal of Medical Sciences - Category: General Medicine Authors: Source Type: research
At least eight pregnant Mississippi women have died of Covid-19 since late July -- none of them fully vaccinated -- officials said, more...
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Blogging | Family Practices | Graduation | Hospital Management | Hospitals | Learning | Nurses | Nursing | Pediatricians | Pediatrics | Penicillin | Pregnancy | Pumpkins | Residencies | Salaries | Solo Practices | Training | Universities & Medical Training | Vaccines